Etzer Darout's
Stock Forecasts

Etzer Darout win rate

2.38%

1/42 win trades

Etzer Darout is a Wall Street stock analyst with a 2.38% win rate, who was right in predicting 1 out of 42 price targets. Most frequently covered stocks by this analyst are MRUS, SRRK, CTMX and ACRV. He has published 0 price targets in the last month and 23 last year.

Price targets by Etzer Darout

Company name & ticker Publish date Price target Price when posted Source Historical targets
NRIX logo
Nurix Therapeutics, Inc.
NRIX
9 months ago $35 253.89% upside $20.06 StreetInsider Previous targets (0)
IGMS logo
IGM Biosciences, Inc.
IGMS
9 months ago $21 1540.62% upside $9.46 StreetInsider Previous targets (0)
PTGX logo
Protagonist Therapeutics, Inc.
PTGX
9 months ago $62 10.32% upside $41.68 StreetInsider Previous targets (0)
KYMR logo
Kymera Therapeutics, Inc.
KYMR
9 months ago $55 29.19% upside $44.08 StreetInsider Previous targets (0)
JSPR logo
Jasper Therapeutics, Inc.
JSPR
9 months ago $63 2134.04% upside $21.53 StreetInsider Previous targets (0)
TRML logo
Tourmaline Bio, Inc.
TRML
9 months ago $50 123.51% upside $24.03 StreetInsider Previous targets (0)
QTTB logo
Q32 Bio Inc.
QTTB
9 months ago $64 3416.48% upside $23.69 StreetInsider Previous targets (0)
MRUS logo
Merus N.V.
MRUS
9 months ago $95 47.90% upside $48.53 StreetInsider
ACRV logo
Acrivon Therapeutics, Inc. Common Stock
ACRV
10 months ago $27 1915.52% upside $7.92 StreetInsider
SRRK logo
Scholar Rock Holding Corporation
SRRK
10 months ago $39 26.95% upside $26.97 StreetInsider
AZN logo
AstraZeneca PLC
AZN
10 months ago $88 10.63% upside $81.19 StreetInsider
NUVL logo
Nuvalent, Inc.
NUVL
10 months ago $134 78.66% upside $69.99 StreetInsider Previous targets (0)
FATE logo
Fate Therapeutics, Inc.
FATE
10 months ago $5 338.67% upside $3.37 StreetInsider
YMAB logo
Y-mAbs Therapeutics, Inc.
YMAB
10 months ago $24 181.35% upside $15.06 StreetInsider
CTMX logo
CytomX Therapeutics, Inc.
CTMX
10 months ago $3.68 83.99% upside $1.09 StreetInsider
BNTX logo
BioNTech SE
BNTX
10 months ago $126 12.09% upside $108.97 StreetInsider
NVS logo
Novartis AG
NVS
10 months ago $120 -4.45% downside $109.91 StreetInsider
EXEL logo
Exelixis, Inc.
EXEL
10 months ago $36 -4.10% downside $32.56 StreetInsider Previous targets (0)
CCCC logo
C4 Therapeutics, Inc.
CCCC
12 months ago $20 629.92% upside $6.87 StreetInsider Previous targets (0)
TERN logo
Terns Pharmaceuticals, Inc.
TERN
12 months ago $26 312.03% upside $8.96 TheFly
XNCR logo
Xencor, Inc.
XNCR
about 1 year ago $32 313.43% upside $20.9 StreetInsider Previous targets (0)
MGNX logo
MacroGenics, Inc.
MGNX
over 1 year ago $8 429.80% upside $14.67 TheFly Previous targets (0)
GMAB logo
Genmab A/S
GMAB
over 1 year ago $48 101.51% upside $29.16 StreetInsider Previous targets (0)

Other analysts covering same stocks

Andrew Ang
UBS
100%
win rate
Covering:
Covering:
Covering:
Covering:
Covering:
Covering: